The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of pandemic on accrual of minority participants to interventional cancer clinical trials.
 
Jaia Wingard
No Relationships to Disclose
 
Vicki Sallee
No Relationships to Disclose
 
Peter Edward Gabriel
No Relationships to Disclose
 
Abigail Doucette
No Relationships to Disclose
 
Wallace P Wormley
No Relationships to Disclose
 
Colleen M. Grosso
No Relationships to Disclose
 
Robert A. Schnoll
No Relationships to Disclose
 
Armenta L. Washington
No Relationships to Disclose
 
Daniel A Pryma
No Relationships to Disclose
 
Katherine Nathanson
Consulting or Advisory Role - Merck
 
Carmen Guerra
Leadership - Freenome; GlaxoSmithKline; GRAIL; Guardant Health
Stock and Other Ownership Interests - BEAM Therapeutics; crispr therapeutics; Editas Medicine; Intellia Therapeutics
Consulting or Advisory Role - AstraZeneca (I)
Speakers' Bureau - Esperion Therapeutics (I); Janssen (I)
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Esperion Therapeutics (I)
 
Robert H. Vonderheide
Consulting or Advisory Role - BMS GmbH & Co. KG
Patents, Royalties, Other Intellectual Property - Inventor on a licensed patient regarding cancer vaccine antigens; Receives royalties from Children’s Hospital Boston for a licensed research-only monoclonal antibody